Substrate
science

Study Identifies Diverse Genetic Material on Shroud of Turin

Researchers have detected DNA from numerous plant and animal species on the Shroud of Turin, a linen cloth associated with the burial of Jesus Christ. The findings, published in a scientific journal, indicate contamination from various global regions. This adds to ongoing debates about the shroud's origin and authenticity.

NE
1 source·Apr 11, 8:23 AM(48 days ago)·1m read
Study Identifies Diverse Genetic Material on Shroud of TurinSubstrate placeholder — needs review
Audio version
Tap play to generate a narrated version.

The Shroud of Turin is a linen cloth bearing the image of a man, believed by some to be the burial shroud of Jesus Christ. The cloth's authenticity has been debated for centuries, with scientific analyses providing mixed results.

A recent study examined genetic material extracted from the shroud. Researchers identified DNA sequences from a wide array of organisms, including plants and animals from various regions. The samples were collected from various parts of the cloth, including unstained areas and the bloodstained regions.

The analysis involved next-generation sequencing techniques to identify the genetic material.

The study found diverse plant and animal species, as well as DNA from humans. No single geographic origin could be pinpointed due to the diversity of the sequences. According to the researchers, the contamination likely occurred over the shroud's history of handling, display, and storage.

The cloth has been exposed to various factors since its documented history.

These genetic findings contribute to the ongoing scientific inquiry into the shroud's provenance.

The presence of contaminants reflects the cloth's long history of veneration and movement. The study builds on prior research. However, the new data does not resolve questions about the image formation on the cloth, which remains unexplained by current science.

testing may involve improved DNA preservation techniques to distinguish original from contaminating material.

The shroud's custodians maintain it as a relic of Christian tradition, attracting millions of visitors. Scientific examination requires approval, which has been granted selectively. The stakes involve historical, religious, and scientific communities.

Believers view the shroud as a witness to the resurrection, while skeptics see it as an artifact. Ongoing analysis aims to clarify its composition without definitive claims on its religious significance.

Key Facts

Diverse DNA detected
from plants and animals across multiple continents
Shroud dimensions
4.4 meters by 1.1 meters linen cloth
Carbon-14 dating
indicates medieval origin 1260-1390 AD
Study publication
in Heritage journal by University of Padua team
Historical display
first in Lirey, France, in 1355

Story Timeline

4 events
  1. 2022

    Researchers published study identifying diverse DNA on Shroud of Turin.

    1 source@NewScientist
  2. 1988

    Carbon-14 dating placed shroud's origin between 1260 and 1390 AD.

    1 source@NewScientist
  3. 1970s

    Pollen analysis suggested Middle Eastern connections to the shroud.

    1 source@NewScientist
  4. 1355

    Shroud first publicly displayed in Lirey, France.

    1 source@NewScientist

Potential Impact

  1. 01

    Scientific community may pursue advanced DNA sequencing on the shroud.

  2. 02

    Public interest in shroud exhibitions could increase with new findings.

  3. 03

    Religious discussions on shroud's authenticity could intensify among scholars.

  4. 04

    Vatican may approve limited further testing of the artifact.

Transparency Panel

Sources cross-referenced1
Framing risk18/100 (low)
Confidence score70%
Synthesized bySubstrate AI
Word count296 words
PublishedApr 11, 2026, 8:23 AM
Bias signals removed3 across 1 outlet
Signal Breakdown
Loaded 1Editorializing 1Framing 1

Related Stories

WHO Director Visits Congo as Ebola Outbreak SpreadsNpr
science4 hrs ago

WHO Director Visits Congo as Ebola Outbreak Spreads

The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.

Npr
France 24
2 sources
FDA Panel Recommends XFG Variant for Fall Covid Shotsmedpagetoday.com
science2 hrs agoDeveloping

FDA Panel Recommends XFG Variant for Fall Covid Shots

Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.

Stat
1 source
Benzinga Publishes Article on Biotech Stocks During Pandemic Recoveryfinance.yahoo.com
science6 hrs agoDeveloping

Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery

Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…

Benzinga
1 source